镰状细胞视网膜病变失访研究
该研究回顾了2012年1月至2021年12月在Wills眼科医院视网膜服务就诊的成人镰状细胞视网膜病变患者,比较至少一次失访(LTFU)事件者与全部按时就诊者的结局。共纳入94例患者181眼,46%的患者有至少一次LTFU事件,平均失访时长470天。LTFU组最终随访和失访后随访视力较失访前显著变差,而全部按时就诊组最终随访视力较初诊显著改善。
要点
- 46%的镰状细胞视网膜病变患者至少经历一次失访事件,平均失访时长470天。
- 失访组最终随访视力较失访前显著变差(P=0.001)。
- 全部按时就诊组最终随访视力较初诊显著改善(P=0.038)。
核心结论
- 发生失访事件的镰状细胞视网膜病变患者与全部按时就诊的患者相比视力结局更差。
研究设计与样本
- 回顾性研究,纳入2012年1月至2021年12月在Wills眼科医院视网膜服务就诊、就诊次数>2次的成人镰状细胞视网膜病变患者,共94例患者181眼;失访定义为未在预约日期后6个月内返回随访。
主要发现
- 51例患者(99眼)全部按时就诊(「按时就诊组」),43例患者(82眼)即46%至少发生一次失访事件(「失访组」)。
- 失访组平均(SD)失访时长为470(329)天。
- 失访组最终随访平均(SD)视力为logMAR 0.45(0.63)、Snellen 20/56,失访后随访为0.36(0.59)、20/46,均较失访前0.3(0.47)、20/40显著变差(P=0.001)。
- 按时就诊组最终随访平均(SD)视力为0.41(0.63)、20/51,较初诊0.52(0.78)、20/66显著改善(P=0.038)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the outcomes of patients with sickle cell retinopathy who experienced at least one episode of being lost to follow-up (LTFU) compared with those who attended all appointments. METHODS: Adult patients with sickle cell retinopathy who visited Wills Eye Hospital Retina service (January 2012-December 2021) with >2 visits were reviewed for LTFU events, defined as failure to return for a follow-up appointment within 6 months of the scheduled date. RESULTS: One hundred and eighty-one eyes of 94 patients were included. Fifty-one patients (99 eyes) attended all appointments ("attended group"), whereas 43 patients (82 eyes), or 46%, had at least one LTFU event ("LTFU group"). The mean (SD) LTFU duration was 470 (329) days. In the LTFU group, mean (SD) VA was significantly worse at the final visit (logMAR 0.45 (0.63), Snellen 20/56) and at the post-LTFU visit (0.36 (0.59), 20/46) compared with the pre-LTFU visit (0.3 (0.47), 20/40, P = 0.001). In the attended group, mean (SD) VA was significantly better at the final visit (0.41 (0.63), 20/51) compared with the initial visit (0.52 (0.78), 20/66, P = 0.038). CONCLUSION: Patients with sickle cell retinopathy with an LTFU event have worse visual outcomes compared with patients who attend all appointments.
引用
- Wong JCY, Sivalingam MD, Griffin M, et al. SICKLE CELL RETINOPATHY LOST TO FOLLOW-UP STUDY. Retina. 2025. PMID: 39661943. doi:10.1097/IAE.0000000000004369
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。